abstract |
This invention is directed to compounds of the formula (I): n nwherein one of R 6 , R 7 , R 8 and R 9 isn n nand X, R 1 to R 12 , m, n and o are as defined in the description, and pharmaceutically acceptable salts and/or esters thereof. The invention is also directed to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are modulated by PPARĪ“ and/or PPARĪ± agonists. |